wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42425704-964549A5-AC7F-4305-AC6F-A27804A560C6
Q42425704-964549A5-AC7F-4305-AC6F-A27804A560C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42425704-964549A5-AC7F-4305-AC6F-A27804A560C6
Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma.
P2860
Q42425704-964549A5-AC7F-4305-AC6F-A27804A560C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42425704-964549A5-AC7F-4305-AC6F-A27804A560C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5b7765944ef69a07b0f46e116830a5b5589f4905
P2860
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma.